The correction factor (CF) is a critical parameter for backestimating the consumption of a drug via wastewater-based epidemiology (WBE). The CF is usually the excretion factor (EF) of the drug or metabolite (the fraction of drug excreted after consumption and the molecular mass ratio of parent drug/metabolite) traditionally determined by human pharmacokinetic studies. An alternative approach to derive CFs is to compare the consumption data with the loads measured by WBE in representative wastewater samples. For this purpose, during the 2016 Australian Census week, more than 500 wastewater samples were collected from 83 wastewater treatment plants across Australia (covering >60% of the Australian population) and analyzed for codeine, methadone, and methadone metabolite, EDDP. National sales data for codeine and methadone to local pharmacies were obtained to estimate the CFs for the three biomarkers. The CFs estimated for codeine and EDDP in this study, 29% (95% CI = 28%−30%) and 50% (95% CI = 49%−52%), respectively, are significantly different from the EFs deduced from pharmacokinetic data (60% and 25%), while methadone's CF is relatively similar to previously used values (22% vs 27.5%). The newly derived CFs were applied to available data in the literature and produced better matches between estimates and consumption data than previously reported. It is thus suggested that the new approach be used to derive the CFs of other drugs of interest for WBE application when limited pharmacokinetic data are available.